-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Bleeding and Clotting Sessions

Friday, December 6, 2024

top

7:00 AM-10:00 AM


Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience + Innovation for More Personalized Disease Control  
Friday Satellite Symposia

11:00 AM-2:00 PM


A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives  
Friday Satellite Symposia

3:00 PM-6:00 PM


Cases and Conversations™: The Rationale for Utilizing Non-Factor Replacement Therapies in Hemophilia Care  
Friday Satellite Symposia


Clinical assessment of gene therapies for hemophilia A and hemophilia B: Key takeaways for your practice  
Friday Satellite Symposia

Saturday, December 7, 2024

top

8:00 AM-9:00 AM


Nonmalignant Hematologic Disorders Forum: Deeper Dive Into PNH, aHUS, and ITP  
Industry Forums

9:00 AM-7:30 PM


Poster Session I - Viewing  
Events

9:30 AM-10:45 AM


The Expanding Landscape of Treatment for ITP  
Education Program


Understanding the Impact of Donor and Recipient Metabolic Variability on Blood Transfusion Outcomes  
Scientific Program

9:30 AM-11:00 AM


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Thrombotic Risk: The Genes We're Born with and Mutations We Acquire  
Oral and Poster Abstracts


401. Blood Transfusion: Advancements in Transfusion Science  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Biological Findings Associated with the Pathophysiology and Outcomes of Aplastic Anemia and PNH  
Oral and Poster Abstracts


703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Novel Cell Platforms and Delivery Strategies  
Oral and Poster Abstracts


ASH ISTH Clinical Practice Guidelines on Treatment of Venous Thromboembolism (VTE) in Pediatric Patients  
Special-Interest Sessions

11:15 AM-12:15 PM


ASH Poster Walk on Hemostasis and Thrombosis: from Basic Concepts to Clinical Applications Hosted by Blood Vessels, Thrombosis & Hemostasis (For In-person Participants)  
ASH Poster Walks


Career Development Lunch
Trainee Activities and Services

12:00 PM-1:30 PM


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Know Thy(mus) Self, Know Thy Enemy: From Lymphocyte Genetic Variation to Disease  
Oral and Poster Abstracts


322. Hemophilia A and B: Clinical and Epidemiological: Beyond Efficacy of Hemostatic Agents in Hemophilia: Exploring Pharmacokinetics, Dosing Regimens, and Special Populations  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Humoral Coagulation Factors: Venous Thrombosis and Beyond  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: A Brave New World: Novel Tools, Targets and Treatments in TTP  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Optimizing Classical Hematology Care  
Oral and Poster Abstracts

2:00 PM-3:15 PM


Beyond TTP: "Atypical" TMAs for the Hematologist  
Education Program


Hematologic Challenges at the End-of-Life  
Education Program


Hematologic Management of the Patient with Heavy Menstrual Bleeding  
Education Program

2:00 PM-3:30 PM


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Platelets and Endothelium in Thrombotic Disorders  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Disease Modeling and Molecular Mechanisms  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: It's All About the Money!  
Oral and Poster Abstracts

4:00 PM-5:15 PM


HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia  
Education Program


Interface of Complement and Coagulation  
Scientific Symposia

4:00 PM-5:30 PM


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Thrombosis in Pregnancy and Childhood  
Oral and Poster Abstracts

4:00 PM-5:35 PM


JOINT SESSION: Newly Described Functions in the Vascular Space  
Scientific Program

5:30 PM-7:30 PM


Poster Session I - Presentations (for in-person participants)  
Events


301. Platelets and Megakaryocytes: Basic and Translational: Poster I  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational: Poster I  
Oral and Poster Abstracts


322. Hemophilia A and B: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster I  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I  
Oral and Poster Abstracts


803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I  
Oral and Poster Abstracts


909. Education, Communication, and Workforce: Poster I  
Oral and Poster Abstracts

Sunday, December 8, 2024

top

8:00 AM-9:00 AM


The Science Behind HYMPAVZI (Marstacimab-hncq): Introducing an Innovative Treatment Option from Pfizer  
Product Theaters

9:00 AM-8:00 PM


Poster Session II - Viewing  
Events

9:30 AM-10:45 AM


Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies  
Scientific Symposia

9:30 AM-11:00 AM


301. Platelets and Megakaryocytes: Basic and Translational: Megakarocyte and Platelet Biology: From Formation to Function  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational. A Coagulation Grab Bag  
Oral and Poster Abstracts

11:30 AM-12:30 PM


Discover Gene Therapy as a Treatment Option for Hemophilia B  
Product Theaters

12:00 PM-1:30 PM


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Big Data and Basic Science  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Novel Treatments and Outcomes  
Oral and Poster Abstracts


909. Education, Communication, and Workforce: Bridging the Gap: Enhancing Communication and Education for Hematologists and our Patients  
Oral and Poster Abstracts

4:30 PM-5:45 PM


Challenges in Cancer-Associated Thrombosis  
Education Program


Newly Discovered Functions of Megakaryocytes and Platelets  
Scientific Symposia


Paradigm Shifts in Hemostasis: From Mechanisms to Therapies and Back  
Scientific Program

4:30 PM-6:00 PM


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Practice-Changing Outcomes Research for Patients with Thrombosis  
Oral and Poster Abstracts

4:30 PM-6:30 PM


Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management  
Special-Interest Sessions

6:00 PM-8:00 PM


Poster Session II - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster II  
Oral and Poster Abstracts


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


301. Platelets and Megakaryocytes: Basic and Translational: Poster II  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational: Poster II  
Oral and Poster Abstracts


322. Hemophilia A and B: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


401. Blood Transfusion: Poster II  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II  
Oral and Poster Abstracts


506. Bone Marrow Microenvironment: Poster II  
Oral and Poster Abstracts


631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II  
Oral and Poster Abstracts


801. Gene Therapies: Poster II  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II  
Oral and Poster Abstracts


908. Outcomes Research: Myeloid Malignancies: Poster II  
Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM


Poster Session III - Viewing  
Events

10:30 AM-11:45 AM


Anticoagulation SOS: Navigating Monitoring Conundrums  
Education Program

10:30 AM-12:00 PM


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Clinical Evidence in ITP  
Oral and Poster Abstracts


322. Hemophilia A and B: Clinical and Epidemiological: Impact of Novel Therapies on Outcomes, Including Long-Term  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Innovative Approaches to Improve Care for Understudied Non-Malignant Hematologic Diseases  
Oral and Poster Abstracts

2:45 PM-4:00 PM


Gene Therapy and Hemophilia A: What Is the Future of Curative Therapy in the Age of Emicizumab?  
Spotlight Sessions


Iron at the Crossroads Between Erythropoiesis and Megakaryopoiesis  
Spotlight Sessions


Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?  
Education Program

2:45 PM-4:15 PM


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Thrombosis: Models, Risk Factors, and Outcomes  
Oral and Poster Abstracts

4:30 PM-5:45 PM


Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist  
Education Program

4:30 PM-6:00 PM


801. Gene Therapies: Gene Therapies for Hemophilia, Cancer and Immunodeficiencies  
Oral and Poster Abstracts


Special Symposium on the Basic Science of Hemostasis and Thrombosis  
Scientific Symposia

6:00 PM-7:30 PM


ASH Networking Reception for the Hemostasis and Thrombosis Community - Hosted by the Blood Vessels, Thrombosis and Hemostasis Journal  
Special-Interest Sessions

6:00 PM-8:00 PM


Poster Session III - Presentations (for in-person participants)  
Events


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


301. Platelets and Megakaryocytes: Basic and Translational: Poster III  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational: Poster III  
Oral and Poster Abstracts


322. Hemophilia A and B: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster III  
Oral and Poster Abstracts


631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III  
Oral and Poster Abstracts


634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts